Eric Aguiar - Net Worth and Insider Trading
Eric Aguiar Net Worth
The estimated net worth of Eric Aguiar is at least $3.0 Billion dollars as of 2024-11-13. Eric Aguiar is the Director, 10% Owner of Eidos Therapeutics Inc and owns about 24,575,501 shares of Eidos Therapeutics Inc (EIDX) stock worth over $3.0 Billion. Eric Aguiar is the Director of Biohaven Pharmaceutical Holding Co Ltd and owns about 1,250 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) stock worth over $17,600. Eric Aguiar is also the Director of Invitae Corp and owns about 0 shares of Invitae Corp (NVTAQ) stock worth over $0. Details can be seen in Eric Aguiar's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Eric Aguiar has not made any transactions after 2020-12-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Eric Aguiar
Eric Aguiar Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Eric Aguiar owns 8 companies in total, including Invitae Corp (NVTAQ) , BridgeBio Pharma Inc (BBIO) , and Eidos Therapeutics Inc (EIDX) among others .
Click here to see the complete history of Eric Aguiar’s form 4 insider trades.
Insider Ownership Summary of Eric Aguiar
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NVTAQ | Invitae Corp | 2020-12-16 | director |
| BBIO | BridgeBio Pharma Inc | 2019-06-27 | director |
| EIDX | Eidos Therapeutics Inc | 2020-05-27 | director |
 | | 2020-01-22 | director |
| | 2013-07-15 | 10 percent owner |
| | 2007-08-02 | other: member of Section 13(d) group |
| | 2006-06-27 | 10 percent owner |
| | 2021-04-15 | director |
Eric Aguiar Latest Holdings Summary
Eric Aguiar currently owns a total of 3 stocks. Among these stocks, Eric Aguiar owns 24,575,501 shares of Eidos Therapeutics Inc (EIDX) as of July 3, 2019, with a value of $3.0 Billion and a weighting of 100%. Eric Aguiar owns 1,250 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) as of January 22, 2020, with a value of $17,600 and a weighting of 0%. Eric Aguiar also owns 0 shares of Invitae Corp (NVTAQ) as of December 16, 2020, with a value of $0 and a weighting of 0%.
Latest Holdings of Eric Aguiar
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| EIDX | Eidos Therapeutics Inc | 2019-07-03 | 24,575,501 | 122.21 | 3,003,371,977 |
| BHVN | Biohaven Pharmaceutical Holding Co Ltd | 2020-01-22 | 1,250 | 14.08 | 17,600 |
| NVTAQ | Invitae Corp | 2020-12-16 | 0 | 0.00 | 0 |
Holding Weightings of Eric Aguiar
Eric Aguiar Form 4 Trading Tracker
According to the SEC Form 4 filings, Eric Aguiar has made a total of 0 transactions in Eidos Therapeutics Inc (EIDX) over the past 5 years. The most-recent trade in Eidos Therapeutics Inc is the acquisition of 882,353 shares on July 3, 2019, which cost Eric Aguiar around $26 Million.
According to the SEC Form 4 filings, Eric Aguiar has made a total of 5 transactions in Biohaven Pharmaceutical Holding Co Ltd (BHVN) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Biohaven Pharmaceutical Holding Co Ltd is the sale of 2,021 shares on January 22, 2020, which brought Eric Aguiar around $114,146.
According to the SEC Form 4 filings, Eric Aguiar has made a total of 3 transactions in Invitae Corp (NVTAQ) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Invitae Corp is the sale of 10,000 shares on December 16, 2020, which brought Eric Aguiar around $510,000.
Insider Trading History of Eric Aguiar
- 1
Eric Aguiar Trading Performance
GuruFocus tracks the stock performance after each of Eric Aguiar's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Eric Aguiar is 36.64%. GuruFocus also compares Eric Aguiar's trading performance to market benchmark return within the same time period. The performance of stocks bought by Eric Aguiar within 3 months outperforms 3 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Eric Aguiar's insider trading performs compared to the benchmark.
Performance of Eric Aguiar
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 0.73 | | | | | |
| Relative Return to S&P 500(%) | -1.13 | | | | | |
Eric Aguiar Ownership Network
Ownership Network List of Eric Aguiar
Ownership Network Relation of Eric Aguiar
Eric Aguiar Owned Company Details
What does Invitae Corp do?
Who are the key executives at Invitae Corp?
Eric Aguiar is the director of Invitae Corp. Other key executives at Invitae Corp include Chief Financial Officer Ana J. Schrank , Chief Commercial Officer Robert M. Guigley , and See Remarks Robert Iv Dickey .
Invitae Corp (NVTAQ) Insider Trades Summary
Over the past 18 months, Eric Aguiar made no insider transaction in Invitae Corp (NVTAQ). Other recent insider transactions involving Invitae Corp (NVTAQ) include a net sale of 90,864 shares made by Kenneth D. Knight , a net sale of 86,904 shares made by Yafei Wen , and a net sale of 33,562 shares made by Robert L Nussbaum .
In summary, during the past 3 months, insiders sold 0 shares of Invitae Corp (NVTAQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 266,444 shares of Invitae Corp (NVTAQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 266,444 shares.
Invitae Corp (NVTAQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Invitae Corp Insider Transactions
Eric Aguiar Mailing Address
Above is the net worth, insider trading, and ownership report for Eric Aguiar. You might contact Eric Aguiar via mailing address: 888 7th Avenue, 12th Floor, New York Ny 10106.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
